0001209191-24-002098.txt : 20240123
0001209191-24-002098.hdr.sgml : 20240123
20240123172241
ACCESSION NUMBER: 0001209191-24-002098
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240122
FILED AS OF DATE: 20240123
DATE AS OF CHANGE: 20240123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JAIN ABHINAV
CENTRAL INDEX KEY: 0001981291
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35068
FILM NUMBER: 24553568
MAIL ADDRESS:
STREET 1: C/O AYTU BIOPHARMA, INC.
STREET 2: 373 INVERNESS PARKWAY, SUITE 206
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TALPHERA, INC.
CENTRAL INDEX KEY: 0001427925
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1850 GATEWAY DRIVE
STREET 2: SUITE 175
CITY: SAN MATEO
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-216-3500
MAIL ADDRESS:
STREET 1: 1850 GATEWAY DRIVE
STREET 2: SUITE 175
CITY: SAN MATEO
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: ACELRX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20080222
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-22
0
0001427925
TALPHERA, INC.
TLPH
0001981291
JAIN ABHINAV
C/O TALPHERA, INC.
1850 GATEWAY DRIVE, SUITE 175
SAN MATEO
CA
94404
1
0
0
0
0
Common Stock
2024-01-22
4
A
0
871
0.00
A
871
D
Stock Option (Right to Buy)
0.912
2024-01-22
4
A
0
5228
0.00
A
2034-01-22
Common Stock
5228
5228
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The restricted stock units shall vest in three equal consecutive annual installments on January 22, 2025, January 22, 2026 and January 22, 2027.
The shares subject to the option vest as follows: 33% of the shares subject to the option vest on the one year anniversary of the Vesting Commencement Date and the remaining shares subject to the option vest on an equal monthly basis over the following 24 months.
/s/ Martha Adler, Attorney-In-Fact
2024-01-23